| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660464A1 Caspase inhibitors containing isoxazoline ring |
| 05/31/2006 | EP1660428A1 Ppar modulators |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1659863A2 Pesticidally active phenol derivatives |
| 05/31/2006 | EP1390356B1 Arylisoxazoline derivatives, method for production and use thereof as pesticides |
| 05/31/2006 | EP1315500A4 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 05/31/2006 | CN1257895C Isoxazoline derivative and herbicide comprising the same as active ingredient |
| 05/31/2006 | CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect |
| 05/30/2006 | US7053094 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure |
| 05/30/2006 | US7052742 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 05/26/2006 | WO2006055184A2 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
| 05/26/2006 | WO2006054652A1 Amide compound |
| 05/26/2006 | WO2006054102A1 Microcin b17 analogs and methods for their preparation and use |
| 05/26/2006 | CA2587678A1 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
| 05/26/2006 | CA2587224A1 Microcin b17 analogs and methods for their preparation and use |
| 05/26/2006 | CA2584619A1 Amide compound |
| 05/25/2006 | US20060111353 2-Cyclohexyl-1-(4-methanesulfonyl-phenyl)-cyclopropanecarboxylic acid 5-chloro-thiazol-2-yl)-amide; antidiabetic agents; non-insulin dependent diabetes; disorders associated with GK dysfunction; an enhanced solubility profile; improved metabolic stability; increased insulin secretion |
| 05/24/2006 | EP1658285A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | EP1658273A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | EP1658267A2 Inhibitors of cathepsin s |
| 05/24/2006 | CN1775765A Method for synthesizing 4, 4-dimethyl-iso-xazole-3-one |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006037480A8 Hexafluoroisopropanol substituted ether derivatives |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/17/2006 | EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 05/17/2006 | EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045532 ACE-2 modulating compounds and methods of use thereof |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/10/2006 | EP1654324A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 05/10/2006 | EP1654247A1 Alkynyl aryl carboxamides |
| 05/10/2006 | CN1771235A Isoxazole compounds |
| 05/10/2006 | CN1255377C Intermediate for preparing isoxazolinyl-3-acylbenzene and process for preparing said intermediate |
| 05/10/2006 | CN1255103C Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/04/2006 | WO2006046914A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006045554A1 (biphenyl) carboxylic acids and derivatives thereof |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | US20060094694 Heterocyclic compounds and thrombopoietin receptor activators |
| 05/04/2006 | CA2584664A1 (biphenyl) carboxylic acids and derivatives thereof |
| 05/04/2006 | CA2584409A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | CN1768031A Novel hydroxamates as therapeutic agents |
| 05/02/2006 | US7038059 Process for preparation of 4-n-substituted amino-2-aza-1-oxabicyclo[3.3.0] oct-2-ene-6-carboxylic acid esters and process for preparation of their intermediates |
| 05/02/2006 | US7037940 Taxol enhancer compounds |
| 05/02/2006 | US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 04/27/2006 | WO2006044412A1 Novel b1 bradykinin receptor antagonists |
| 04/27/2006 | WO2006044359A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 04/27/2006 | WO2006042478A1 Small-molecule inhibitors of coronaviral main protease, their preparation and use |
| 04/27/2006 | US20060089398 Isoxazole carboxamide derivatives as ghrelin receptor modulators |
| 04/27/2006 | US20060089371 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 04/27/2006 | US20060089365 Heterocyclic compounds useful as nurr-1 activators |
| 04/27/2006 | CA2583267A1 Novel b1 bradykinin receptor antagonists |
| 04/26/2006 | EP1650199A1 Sulfonamide derivative having isoxazole ring |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034046 NR1H4 nuclear receptor binding compounds |
| 04/25/2006 | US7034045 Monofluoroalkyl derivatives |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/20/2006 | WO2006042245A1 Novel isoxazole compounds having ppar agonist activity |
| 04/20/2006 | WO2006040351A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
| 04/20/2006 | US20060084814 Process for the preparation of zonisamide |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084690 Isoxazole derivatives |
| 04/20/2006 | US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084657 Piperazine derivative |
| 04/20/2006 | CA2582180A1 Indazoles, benzisoxazoles and benzisothiazoles, process for preparing them, pharmaceutical compositions and use as estrogenic agents |
| 04/19/2006 | EP1647549A1 Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents |
| 04/19/2006 | EP1646616A2 Combretastatin derivatives with cytotoxic action |
| 04/19/2006 | EP1472236A4 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide |
| 04/19/2006 | EP1420784B1 Compounds effecting glucokinase |
| 04/19/2006 | EP1253924B1 Nitrate salts of antimicrobial agents |
| 04/19/2006 | EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/18/2006 | US7030239 Compounds to treat Alzheimer's disease |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/13/2006 | WO2006038657A1 3-bromo-5,5-dimethyl-4,5-dihydroisoxazole and method for producing same |
| 04/13/2006 | WO2006037982A2 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases |
| 04/13/2006 | WO2006037480A1 Hexafluoroisopropanol substituted ether derivatives |
| 04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
| 04/13/2006 | US20060079562 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 04/13/2006 | US20060079549 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength |
| 04/13/2006 | DE102004023635A1 Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate Heteroaryl-cyclohexyl-1,4-diamine derivatives |
| 04/13/2006 | CA2579091A1 Isoxazoline derivatives and their use as herbicides |
| 04/12/2006 | EP1643992A2 New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates |
| 04/12/2006 | EP1643960A2 Arylsulfonamide derivatives |
| 04/12/2006 | EP1495015B1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |
| 04/12/2006 | EP1003736B1 Substituted 4-benzoyl-pyrazoles |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1759105A Insecticidal phthalamide derivatives |